Literature DB >> 28838632

The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study.

Thilo Hackert1, Oliver Strobel1, Christoph W Michalski1, André L Mihaljevic1, Arianeb Mehrabi1, Beat Müller-Stich1, Christoph Berchtold1, Alexis Ulrich1, Markus W Büchler2.   

Abstract

BACKGROUND: Neoadjuvant therapy is an important strategy for locally advanced pancreatic cancer (PDAC) as resection rates increase with modern chemotherapy regimens even in patients with arterial tumor encasement. The aim of this study is the description of technique and initial outcomes of a new type of radical and arterial-sparing resection after neoadjuvant treatment for locally advanced PDAC.
METHODS: The surgical technique and perioperative results of a new type of operation are described, comprising radical tumor removal by sharp dissection along the celiac axis and the superior mesenteric artery with complete dissection of all soft tissue between both - arteries and superior mesenteric/portal vein (TRIANGLE operation).
RESULTS: 15 patients underwent artery-preserving tumor removal without mortality, 7/15 patients showed postoperative complications and an R0 resection was achieved in 6/15 patients. Functional outcome was good in 11/15 patients despite the extended approach of dissection.
CONCLUSION: After neoadjuvant therapy for locally advanced PDAC, surgical exploration should be attempted in patients with stable disease or remission to clarify true vascular infiltration. In case of absent viable tumor, the described technique allows to perform radical surgery without arterial resection in this subgroup of patients.
Copyright © 2017 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28838632     DOI: 10.1016/j.hpb.2017.07.007

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  27 in total

Review 1.  Resection of Recurrent Pancreatic Cancer: Who Can Benefit?

Authors:  Henrik Nienhüser; Markus W Büchler; Martin Schneider
Journal:  Visc Med       Date:  2021-11-11

Review 2.  Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling.

Authors:  Thomas J Ettrich; Niklas Sturm; Melanie Güthle; Felix J Hüttner; Lukas Perkhofer
Journal:  Visc Med       Date:  2022-01-19

3.  Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.

Authors:  Georgios Gemenetzis; Alex B Blair; Minako Nagai; William R Burns; Christopher L Wolfgang; Jin He; Vincent P Groot; Ding Ding; Ammar A Javed; Richard A Burkhart; Elliot K Fishman; Ralph H Hruban; Matthew J Weiss; John L Cameron; Amol Narang; Daniel Laheru; Kelly Lafaro; Joseph M Herman; Lei Zheng
Journal:  Ann Surg Oncol       Date:  2021-08-27       Impact factor: 5.344

4.  Synchronous arterial resection in pancreatic cancer: A case report.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihai Dimitriu; Cristian Balalau; Florentina Furtunescu; Florentina Gherghiceanu; Daniel Radavoi; Camelia Diaconu; Ovidiu Stiru; Cornel Savu; Vladislav Brasoveanu; Claudia Stoica; Ioan Cordos
Journal:  Exp Ther Med       Date:  2022-03-15       Impact factor: 2.447

Review 5.  [Surgical treatment of pancreatic cancer-What is new?]

Authors:  Thomas Schmidt; Orlin Belyaev; Waldemar Uhl; Christiane J Bruns
Journal:  Chirurg       Date:  2022-03-31       Impact factor: 0.955

6.  Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis.

Authors:  Dong Xu; Kai Zhang; Mingna Li; J P Neoptolemos; Junli Wu; Wentao Gao; Pengfei Wu; Baobao Cai; Jie Yin; Guodong Shi; Zipeng Lu; Kuirong Jiang; Yi Miao
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

Review 7.  What do surgeons need to know about the mesopancreas.

Authors:  Eduardo de Souza M Fernandes; Oliver Strobel; Camila Girão; Jose Maria A Moraes-Junior; Orlando Jorge M Torres
Journal:  Langenbecks Arch Surg       Date:  2021-06-12       Impact factor: 3.445

8.  Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy.

Authors:  Caitlin A McIntyre; Constantinos P Zambirinis; Alessandra Pulvirenti; Joanne F Chou; Mithat Gonen; Vinod P Balachandran; T Peter Kingham; Michael I D'Angelica; Murray F Brennan; Jeffrey A Drebin; William R Jarnagin; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2020-05-25       Impact factor: 5.344

Review 9.  Optimizing the outcomes of pancreatic cancer surgery.

Authors:  Oliver Strobel; John Neoptolemos; Dirk Jäger; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2019-01       Impact factor: 66.675

Review 10.  Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy.

Authors:  Danko Mikulic; Anna Mrzljak
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.